Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Operating Margin Over TimeStrong
Percentile Rank67
Studio
Year-over-Year Change

Operating income as a percentage of revenue

Latest
-231.58%
↑ 93% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive declineStrong
Average
-3393.04%
Historical baseline
PeriodValueYoY Change
TTM-231.58%-
20240.00%+100.0%
2023-27347.97%-651.3%
2022-3640.23%-939.1%
2021-350.33%-
20200.00%+100.0%
2018-1169.32%-119.9%
2017-531.72%-12.3%
2016-473.34%-154.6%
2015-185.95%-